Testing effectiveness (Phase 2)Study completedNCT00003131What this trial is testingCMA-676 in Treating Patients With Acute Myeloid Leukemia in First RelapseWho this might be right forLeukemia Pfizer 55
Early research (Phase 1)WithdrawnNCT05456269What this trial is testingBisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDSWho this might be right forAcute Myeloid LeukemiaRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia+2 more Racura Oncology Ltd
Post-approval studies (Phase 4)UnknownNCT02690922What this trial is testingLow-dose Chemotherapy Combine With Tyrosine Kinase Inhibitor to Treat ph+ Acute Lymphoblastic Leukemia PatientsWho this might be right forph+ Acute Lymphoblastic Leukemia Tongji Hospital 40
Not applicableActive Not RecruitingNCT04167683What this trial is testingMuscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell TransplantWho this might be right forHematologic DiseasesChronic Myeloid LeukemiaAcute Myeloid Leukemia+5 more Rigshospitalet, Denmark 144
Early research (Phase 1)Study completedNCT00038051What this trial is testingEvaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid MalignanciesWho this might be right forAcute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyeloproliferative Disorders+1 more M.D. Anderson Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT00005802What this trial is testingChemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic LeukemiaWho this might be right forLeukemia Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02017457What this trial is testingAzacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation.Who this might be right forAcute Myelogenous LeukemiaMyelodysplastic Syndrome Carlos Graux, MD, PhD 50
Early research (Phase 1)Ended earlyNCT01159301What this trial is testingEntinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid LeukemiaWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+16 more National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Ended earlyNCT03523429What this trial is testingPETHEMA-BLIN-01/PET069014 (BLIN-01)Who this might be right forPhiladelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL PETHEMA Foundation 11
Early research (Phase 1)Study completedNCT04372433What this trial is testingIO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMMLWho this might be right forAML With Monocytic DifferentiationCMML Immune-Onc Therapeutics 67
Early research (Phase 1)WithdrawnNCT01478074What this trial is testingALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Altor BioScience
Early research (Phase 1)Ended earlyNCT00469820What this trial is testingVaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell TransplantWho this might be right forLeukemiaMultiple Myeloma and Plasma Cell Neoplasm Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Not applicableStudy completedNCT00321880What this trial is testingHealing Touch in Treating Patients Receiving Chemotherapy for Acute Myeloid Leukemia or Acute Lymphocytic LeukemiaWho this might be right forFatigueLeukemiaPsychosocial Effects of Cancer and Its Treatment Wake Forest University Health Sciences 40
Early research (Phase 1)Study completedNCT03194685What this trial is testingStudy of FF-10101-01 in Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAML, Adult Fujifilm Pharmaceuticals U.S.A., Inc. 97
Testing effectiveness (Phase 2)Study completedNCT00796068What this trial is testingTreosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood TransplantWho this might be right forAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+4 more Fred Hutchinson Cancer Center 130
Early research (Phase 1)WithdrawnNCT02815059What this trial is testingStudy of Pts With Philadelphia Chromosome-Pos ALL With Comb of Ibrutinib, Dasatinib, and PrednisoneWho this might be right forAcute Lymphoblastic Leukemia University of Utah
Large-scale testing (Phase 3)Looking for participantsNCT07478991What this trial is testingAzacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)Who this might be right forAcute Myeloid Leukemia, Adult PETHEMA Foundation 376
Early research (Phase 1)Ended earlyNCT05654779What this trial is testingCLL-1/CD33 Targeted LCAR-AMDR Cells in Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Institute of Hematology & Blood Diseases Hospital, China 4
Large-scale testing (Phase 3)Ended earlyNCT00324324What this trial is testingMoxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more OHSU Knight Cancer Institute 240
Testing effectiveness (Phase 2)Study completedNCT02249091What this trial is testingA Phase II Study of Selinexor Plus Cytarabine and Idarubicin in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia (Relapsed/Refractory) GSO Global Clinical Research BV 42